Disclosure. RV is not the innocent bystander 10/1/16. Assessment and Management of Pulmonary Heart Disease in the Female Patient

Similar documents
Pulmonary Hypertension: Echocardiographic Evaluation of Pulmonary Hypertension and Right Ventricular Function. Irmina Gradus-Pizlo, MD

Echo in Pulmonary HTN

Echo Doppler Assessment of Right and Left Ventricular Hemodynamics.

2/4/2011. Nathan Kerner, M.D.

Quantitation of right ventricular dimensions and function

Comprehensive Hemodynamics By Doppler Echocardiography. The Echocardiographic Swan-Ganz Catheter.

P = 4V 2. IVC Dimensions 10/20/2014. Comprehensive Hemodynamic Evaluation by Doppler Echocardiography. The Simplified Bernoulli Equation

Pulmonary Hypertension: Another Use for Viagra

Pulmonary Hypertension in 2012

Squeeze, Squeeze, Squeeze: The Importance of Right Ventricular Function and PH

THE RIGHT VENTRICLE IN PULMONARY HYPERTENSION R. DRAGU

Disclosures. Objectives. RV vs LV. Structure and Function 9/25/2016. A Look at the Other Side: Focus on the Right Ventricle and Pulmonary Hypertension

Right Heart Hemodynamics: Echo-Cath Discrepancies

Right Heart Catheterization. Franz R. Eberli MD Chief of Cardiology Stadtspital Triemli, Zurich

Disclosures. Objectives 6/16/2016. A Look at the Other Side: Focus on the Right Ventricle and Pulmonary Hypertension

Assessing the Impact on the Right Ventricle

Pulmonary Hypertension. Echocardiography: Pearls & Pitfalls

Καθετηριασμός δεξιάς κοιλίας. Σ. Χατζημιλτιάδης Καθηγητής Καρδιολογίας ΑΠΘ

HEMODYNAMIC ASSESSMENT

Chamber Quantitation Guidelines - Update II

Clinical implication of exercise pulmonary hypertension: when should we measure it?

PULMONARY HYPERTENSION

Pulmonary Hypertension Due to Left Heart Disease

Anjali Vaidya, MD, FACC, FASE, FACP Associate Director, Pulmonary Hypertension, Right Heart Failure, and Pulmonary Thromboendarterectomy Program

Right Ventricle Steven J. Lester MD, FACC, FRCP(C), FASE Mayo Clinic, Arizona

The Hemodynamics of PH Interpreting the numbers

Real life management of CTEPH: patient case

2nd ECHO ASE-ASEAN: Bangkok 22nd October DR. TAN JU LE Pulmonary Hypertension Services National Heart Centre SINGAPORE

Right Ventricular Failure and Pulmonary Hypertension 2011

CTEPH and CTED. Diseases that hide in plain sight to the eye, the mind, philosophically

Pulmonary Hypertension: Clinical Features & Recent Advances

DOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES

Dr. Md. Rajibul Alam Prof. of Medicine Dinajpur Medical college

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension

Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction

Diastolic Heart Function: Applying the New Guidelines Case Studies

Doppler Basic & Hemodynamic Calculations

Pulmonary Hypertension: A Cardiology Perspective

PVDOMICS. Study Introduction. Kristin Highland, MD Gerald Beck, PhD. NHLBI Pulmonary Vascular Disease Phenomics Program

Disclosures. Afterload on the PV loop. RV Afterload THE PULMONARY VASCULATURE AND ASSESSMENT OF THE RIGHT VENTRICLE

Cardiac Catheterization is Unnecessary in the Evaluation of Patients with Pulmonary Hypertension: CON

PULMONARY HYPERTENSION & THALASSAEMIA

Acute Right Ventricular Failure

Value of echocardiography in chronic dyspnea

An Inconvenient Choice Pulmonary Artery Systolic Pressure of 43 mmhg: Is a Work Up for Pulmonary Hypertension Warranted?

Chamber Quantitation Guidelines II Right Heart Measurements

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics

Evaluation of the Right Ventricle in Candidates for Right Ventricular Assist Device Implantation.

Appendix II: ECHOCARDIOGRAPHY ANALYSIS

PVDOMICS. Study Introduction. Kristin Highland, MD Gerald Beck, PhD. NHLBI Pulmonary Vascular Disease Phenomics Program

Adel Hasanin Ahmed 1

Brief View of Calculation and Measurement of Cardiac Hemodynamics

ECHO HAWAII. My home. Pulmonary Hypertension and Pulmonary Embolism: Role of Echo U.S.A. Japan. Hawaii Island 1/9/2018

Echocardiography: Guidelines for Valve Quantification

Pulmonary vascular remodelling: causes, mechanisms and consequences

Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on)

CONUNDRUMS IN PULMONARY ARTERIAL HYPERTENSION

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

Pulmonary Hypertension: Follow-up in adolescence and adults

RVOTO adult and post-op

Tissue Doppler Imaging in Congenital Heart Disease

ASCeXAM / ReASCE. Practice Board Exam Questions Monday Morning

5 consecutive cases of PH I wish I never saw

Fig.1 Normal appearance of RV in SAX:

The Doppler Examination. Katie Twomley, MD Wake Forest Baptist Health - Lexington

Pulmonary Hypertension: Definition and Unmet Needs

CTED and the Value of Exercise Testing

Transthoracic echocardiography in the evaluation of pediatric pulmonary hypertension and ventricular dysfunction

COMPLEX CONGENITAL HEART DISEASE: WHEN IS IT TOO LATE TO INTERVENE?

Prognostic value of echocardiographic parameters in patients with pulmonary arterial hypertension (PAH) treated with targeted therapies

Choose the grading of diastolic function in 82 yo woman

RIGHT VENTRICULAR SIZE AND FUNCTION

Neonatal and Pediatric Pulmonary Vascular Disease

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with

Diagnosis and assessment of pulmonary vascular disease by Doppler echocardiography

좌심실수축기능평가 Cardiac Function

MAKING SENSE OF MODERATE GRADIENTS IN PATIENTS WITH SYMPTOMATIC AORTIC STENOSIS

Pulmonary hypertension in clinical practice: are we focusing on the problem?

Pulmonary Hypertension: When to Initiate Advanced Therapy. Jonathan D. Rich, MD Associate Professor of Medicine Northwestern University

Pulmonary Hypertension Perioperative Management

Right Heart Evaluation ASE Guidelines Review. Chris Mann RDCS, RCS, FASE Faculty, Echocardiography Pitt Community College Greenville, NC

Update on pulmonary HTN

Anjali Vaidya, MD, FACC, FASE, FACP Associate Director, Pulmonary Hypertension, Right Heart Failure, Pulmonary Thromboendarterectomy Program Advanced

Evaluation of Left Ventricular Function and Hypertrophy Gerard P. Aurigemma MD

Dr.Fayez EL Shaer Consultant cardiologist Assistant professor of cardiology KKUH

Paediatric PAH in the current era

DECLARATION OF CONFLICT OF INTEREST

Atrial dyssynchrony syndrome: An overlooked cause of heart failure with normal ejection fraction

Valutazione del neonato con sospetta ipertensione polmonare

Imaging Assessment of the Pulmonary Valve in Stenosis/Atresia and Regurgitation

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

Adult Echocardiography Examination Content Outline

Mechanical Cardiac Support and Cardiac Transplant: The Role for Echocardiography

Diagnosis is it really Heart Failure?

The right heart: the Cinderella of heart failure

Swan Song: Echocardiography as a Pulmonary Artery Catheter? Interdepartmental Division of Critical Care Medicine

Ref 1. Ref 2. Ref 3. Ref 4. See graph

Pulmonary arterial hypertension. Pulmonary arterial hypertension: newer therapies. Definition of PH 12/18/16. WHO Group classification of PH

Atrial Septal Defects

Screening for CETPH after acute pulmonary embolism: is it needed? Menno V. Huisman Department of Vascular Medicine LUMC Leiden

Transcription:

Assessment and Management of Pulmonary Heart Disease in the Female Patient Oct 1, 2016 Deborah Women s Heart Center Susan E Wiegers, MD, FASE, FACC Professor of Medicine Senior Associate Dean of Faculty Affairs and Graduate Medical Education The Lewis Katz School of Medicine at Temple University Disclosure None related to this presentation RV is not the innocent bystander Ventriculo-arterial coupling RV pumps as much blood at a rate that the pulmonary vasculature can accept Contractility and compliance are balanced 1

Ventriculo-arterial coupling Uncoupling leads to Right heart failure and symptoms of pulmonary heart disease Primary RV failure Changes in pulmonary vascular compliance Or both WHO classification PHTN Group 1 Pulm arterial HTN (PAH) Familial Toxins/Drugs CTD scleroderma HIV, schistosomiasis Portal HTN Congenital Disease 2

WHO classification cont Group 2 due to Left Heart Disease Group 3 due to Lung disease, hypoxia Includes COPD and ILD but also high altitude and OSA, hypoventilation Group 4 CTEPH Group 5 unclear mechanism Chronic hemolytic anemia, sarcoidosis From: Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension! J Am Coll Cardiol. 2013;62(25_S). doi:10.1016/j.jacc.2013.10.025" Figure Legend:! Proposed Multifactorial Factors Influencing Progression of Pulmonary Hypertension" In a suitable genetic background, the interplay of epigenetics and pathobiological injurious events may amplify the severity of the disease, often associated with more pronounced remodeling and worse clinical outcome." " Date of download: 9/15/2016" Copyright The American College of Cardiology. All rights reserved. From: Right Heart Adaptation to Pulmonary Arterial Hypertension: Physiology and Pathobiology! J Am Coll Cardiol. 2013;62(25_S). doi:10.1016/j.jacc.2013.10.027" Figure Legend:! Pathophysiology of RV Dysfunction in PAH" Increased right ventricular (RV) wall stress, neurohormonal activation, inflammation, and altered bioenergetics contribute to RV remodeling in pulmonary arterial hypertension (PAH). Adaptive remodeling is associated with minimally altered ventriculoarterial coupling. Progressive RV dilation with maladaptive remodeling further contributes to RV stress." " Date of download: 9/15/2016" Copyright The American College of Cardiology. All rights reserved. 3

From: Right Heart Adaptation to Pulmonary Arterial Hypertension: Physiology and Pathobiology! J Am Coll Cardiol. 2013;62(25_S). doi:10.1016/j.jacc.2013.10.027" Figure Legend:! Describing Right Ventricular Function" (A) Pressure-volume relation, illustrating the concepts of ventricular elastance (Ees), arterial elastance (Ea), and the maximal isovolumic pressure used to estimate single-beat Ees. (B) Pump function graph, illustrating that when baseline pulmonary vascular resistance (PVR) is high, a decrease in PVR mainly causes an increase in stroke volume, while at lower baseline PVR, pressure is more affected." " Date of download: 9/19/2016" Copyright The American College of Cardiology. All rights reserved. Ventriculo-arterial coupling RV keeping up RV dysfunction Assessment of Right Heart Function Size and wall thickness Interventricular Dependence Contractility Fractional area change TAPSE and tissue Doppler PA systolic pressure Pulmonary vascular resistance 4

RV focused apical view Diameter Basal 33 (>42 abnl) Mid 27 (>35 abnl) Long axis 71 (> 86 abnl) Indexing to BSA may be relevant but no standards Other things can make the right heart look abnormal 5

Ventricular interdepedence due to pericardial constraint RV contractility fractional area change (<35% abnormal) Other measures of contractility Normal Systolic wave Abnormal s (<9.5 abnl) 6

Incorrectly measured 1.4 cm TAPSE More correctly measured 0.8 cm (<1.7 abnormal) Contrast for endocardial border definition 7

PA systolic pressure PASP = 4 v 2 + RAP RAP = Nl RA size, IVC complete collapse - 3 mm Hg Either or = 8 mm Hg RA large, IVC collapse < 50% - 15 mm Hg No IVC collapse - 20 mm Hg Pulmonary Artery Systolic Pressure Measured incorrectly Measured more correctly IVC with sniff RA pressure = 3 mm Hg RA pressure = 15 mm Hg 8

PA diastolic pressure from PR jet End PR velocity 2.5 m/sec PAD = 25 + RAP RA volumes Single plane measurement as opposed to LA biplane measurement 2D measurement underestimates compared to 3D Women 21 ±7 ml/m 2 Men 25 ±7 ml/m 2 9

Pulse wave RVOT Mid-systolic notching c/w elevated PVR Acceleration time shortens as PASP ACT >100 msec not consistent with PHTN Late systolic notch PVR mildly elevated Mid-systolic notch PVR severely elevated 10

Significance of notching Absence suggests normal RV function RV dysfunction in the absence of notching strongly suggests primary RV dysfunction RV dysfunction in the presence of notching afterload dependent mechanism of RV failure Late systolic closure of PV Flying W M-mode sign PVR by echo PVR = TR peak velocity x 10 +0.16 TVI RVOT 11

A simple method for noninvasive estimation of pulmonary vascular resistance! J Am Coll Cardiol. 2003;41(6):1021-1027. doi:10.1016/s0735-1097(02)02973-x" Figure Legend:! Images showing peak tricuspid regurgitant velocity (TRV) and right ventricular outflow time-velocity integral (TVI RVOT ) in a patient with normal pulmonary vascular resistance (PVR). (A) TRV is 2.86 m/s. (B) TVI RVOT is 20.8 cm. The ratio of TRV/TVI RVOT = 2.86/20.8 = 0.1375. PVR ECHO = 0.1375 10 + 0.16 = 1.53 Woodsunits (WU). This patientʼs invasive PVR measurement was within 0.4 WU of the echocardiographic value (PVR CATH = 1.3 WU). PVR ECHO = PVR in WU calculated based on the linear regression equation in which a value for PVR in WU was modeled based on TRV/TVI RVOT. PVR CATH = invasive PVR." " Date of download: 9/29/2016" Copyright The American College of Cardiology. All rights reserved. P = flow x resistance Normal PVR < 1.5 Wood units PHTN > 3 Wood units Echo calculation may be helpful if High systolic pressure appears to be due to increased flow PASP appears low but due to profound RV failure RV Volume overload Young age, athletic training, pregnancy High output states - cirrhosis RV volume loads - ASD, TR, anomalous pulmonary venous return Severe PR rare RV function normal or hyperdynamic TAPSE may be > 2.5 cm Stroke volume high PA velocity > 0.8 m/sec 12

TR jet pattern in profound RV failure Doppler Role imperfections: of Echo-Doppler a forgivable exam? flaw Assignment to diagnostic bins Pulmonary (arterial) Hypertension It s not about the pressure Predictors of outcome in PAH Hemodynamics echocardiography CI Hit the bulls-eye? pericardial effusion RAP Tei index Doppler: PASP 77, mpap -PAH 44, wedge 12, CO PVR TR severity -CTEPH 3.7, PVR 8.6 PA sat -Other TAPSE high PVR conditions -Normal -Left heart disease/pulmonary venous htn -high output, normal PVR 13

Pulmonary Arterial Hypertension vs Chronic Thromboembolic Pulmonary Hypertension Group 1: PAH Remodeling, occlusion, constriction of small pulmonary arteries mpap > 25 mmhg PAWP < 15 PVR > 3 WU Group 4: CTEPH Incomplete resolution of initial or recurrent pulmonary embolism (PE) Thrombosis of main, lobar, or segmental pulmonary arteries High pulmonary vascular resistance (PVR) Remodeling of pulmonary blood vessels CTEPH Epidemiology CTEPH may develop in 4-5% of PE survivors ~19,000 cases per year in the US Up to 50% of patients have no history of symptomatic VTE or confirmed PE First PE-4-5% incidence CTEPH Prior PE-35-40% incidence CTEPH 1. Klok FA et al. Haematologica 2010; 95:970-5 2. Humbert M. Eur Respir Rev 2010; 19 (115): 59 63 3. Kirson NY. Curr Med Res Opin. 2011 Sep; 27 (9): 1763-8 Korkmaz A et al. Clin Appl Thromb Hemost 2012; 18: 281 Case 1 14

Case 2 VQ scan: the gatekeeper of chronic PE imaging A true negative VQ scan!essentially rules out CTEPH CTA and PA gram imaging should stem from results of VQ scan 15

Treatment Plan General measures Supportive therapy anticoagulation, diuretics, O2 Referral centers Vasoreactivity testing Calcium Channel blockers Combination drugs Lung Transplant Survival rate of pulmonary hypertension patients in relation to right ventricular contractile reserve obtained by pulmonary arterial systolic pressure (PASP) increase during exercise. Ekkehard Grünig et al. Circulation. 2013;128:2005-2015 Copyright American Heart Association, Inc. All rights reserved. Measuring clinical response Exercise capacity Cardiac Index RAP NT-proBNP plasma levels Echo parameters 16

60 yo woman, MCTD, severe PAH on combination therapy 2 year stable no progression Conclusions Echo important in diagnosis but requires additional diagnostic procedures Elevated PVR vs Pulmonary venous hypertension can be differentiated based on LV Doppler and PA pulse wave Doppler Echo important in following response to therapy 17

Thank you for your attention 18